Peer-reviewed study shows six times lower blood damage in RealheartĀ® TAH than market-leading device in vitro
Scandinavian Real Heart AB (publ) announces today that a study sponsored by the company has been published in the peer-reviewed journal Nature Scientific Reports, showing that the RealheartĀ® TAH causes…